Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - IntraBiotics Pharmaceut. (NasdaqNM:IBPI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Location
2021 Stierlin Court
Mountain View, CA 94043
Phone: (650) 526-6800
Fax: (650) 969-0663
Email: investors@intrabiotics.com
Employees (last reported count): 141
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 48%
·Institutional: 56% (108% of float)
(65 institutions)
·Net Inst. Selling: 616.0K shares (+3.90%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
IntraBiotics Pharmaceuticals, Inc. develops and intends to commercialize novel antibacterial and anti-fungal drugs for the prevention or treatment of serious infectious diseases. The Company's clinical and development programs focus on solving medical problems for patients who have few or no satisfactory alternatives. Because of their bacteria- or fungi-killing mechanisms, the Company's drug candidates are designed to be useful in fighting microorganisms that are resistant to traditional antibiotics.
More from Market Guide: Expanded Business Description

Financial Summary
IntraBiotics Pharmaceuticals, Inc. develops and intends to commercialize novel antibacterial and antifungal drugs for the prevention or treatment of serious infectious diseases. For the three months ended 3/31/01, the Company reported no revenues. Net loss totalled $18.7 million, up from $7.3 million. Revenues reflect the absence of product and contract sales. Higher loss reflects an increase in personnel and payroll expenses.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, after tax earnings were -34,314. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Kenneth Kelley, 42
Chairman, Pres, CEO
$380K$326K
Sandra Wrobel, 41
CFO, VP, Bus. Operations
235K129K
Donna Caley, 56
VP of Organization Devel.
--  --  
Henry Fuchs, M.D., 43
VP, Clinical Affairs
250K133K
Chee-liang Leo Gu, Ph.D., 50
VP, Pharmaceutical Devel.
190K105K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:IBPIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 16-July-2001
$0.90 
Recent Price$1.58 
52-Week High
on 1-Sep-2000
$20.938
Daily Volume (3-month avg)280.6K
Daily Volume (10-day avg)72.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-92.2%
52-Week Change
relative to S&P500
-89.6%
Share-Related Items
Market Capitalization$46.3M
Shares Outstanding29.3M
Float15.2M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$2.46 
Earnings (ttm)-$2.73 
Earnings (mrq)-$1.17 
SalesN/A 
Cash (mrq*)$2.24 
Valuation Ratios
Price/Book (mrq*)0.64 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
SalesN/A 
EBITDA (ttm*)-$58.1M
Income available to common (ttm)-$79.9M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-72.72%
Return on Equity (ttm)-84.15%
Financial Strength
Current Ratio (mrq*)6.42 
Debt/Equity (mrq*)0.17 
Total Cash (mrq)$51.1M
Short Interest
As of 8-Aug-2001
Shares Short85.0K
Percent of Float0.6%
Shares Short
(Prior Month)
106.0K
Short Ratio0.31 
Daily Volume271.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.